SCHEMBL6704155

SCHEMBL6704155

O=C(O)NCCc1ccc(CN2CCCC2)cc1F

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
HTT P42858 1/20 0.51
MCHR1 Q99705 7/20 0.49
HRH3 Q9Y5N1 3/20 0.46
TSHR P16473 1/20 0.45
DPP4 P27487 1/20 0.45
DPP8 Q6V1X1 1/20 0.45
CYP2D6 P10635 2/20 0.44
CHRM1 P11229 1/20 0.44
HTR2A P28223 1/20 0.44
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP2C9 P11712 1/20 0.43
HIF1A Q16665 1/20 0.43
SIGMAR1 Q99720 1/20 0.42
CCR3 P51677 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1936132 0.81 MCHR1 (0.61) ALDH1A1HTTMCHR1HRH3TSHR
SCHEMBL6704586 0.80 MCHR1 (0.78) ALDH1A1MCHR1CYP2D6CHRM1HTR2A
SCHEMBL2876452 0.79 ALDH1A1 (0.61) ALDH1A1HTTHRH3DPP4DPP8
SCHEMBL1936180 0.79 ALDH1A1 (0.54) ALDH1A1HTTMCHR1HRH3CYP2D6
SCHEMBL6223590 0.79 MCHR1 (0.59) MCHR1HRH3CYP2D6CHRM1HTR2A
SCHEMBL6706610 0.78 CYP1A2 (0.41) TSHRCYP2D6CYP2C9
SCHEMBL6225770 0.78 ALDH1A1 (0.63) ALDH1A1HTTHRH3DPP4DPP8
SCHEMBL28645295 0.76 ALDH1A1 (0.65) ALDH1A1HTTHRH3DPP4DPP8
SCHEMBL2553567 0.72 PDPK1 (0.50) ALDH1A1CYP2D6SMN1; SMN2CYP2C9
SCHEMBL19212130 0.72 AKR1B1 (0.44) HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242572-A1 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242572-A1 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture MCHR2, MCHR1, NPY1R ALDH1A1 3363/4885HTT 1270/4885MCHR1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.